Cite
HARVARD Citation
Habel, L. et al. (2021). Hydrochlorothiazide and risk of melanoma subtypes. Pharmacoepidemiology and drug safety. 30 (10), pp. 1396-1401. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Habel, L. et al. (2021). Hydrochlorothiazide and risk of melanoma subtypes. Pharmacoepidemiology and drug safety. 30 (10), pp. 1396-1401. [Online].